| Particulars |
|
|
|
| Company Name
| Emcure Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
189.57 |
B.V. (₹) |
169.50 |
| Sales(₹ Cr.) |
4,381.92 |
NP (₹ Cr.) |
288.59 |
| NP Var% |
78.00 |
Div% |
30.00 |
| CPS(₹) |
27.10 |
EPS (₹) |
15.20 |
| Traded Value(₹ Lakhs) |
278.11 |
52 Week High |
1,568.00 |
| 52 Week Low |
890.00 |
Price BSE |
1,540.00 |
| Price NSE |
1,541.00 |
Market Capital (₹ Cr.) |
29,196.07 |
| P/C Ratio |
56.80 |
P/E Ratio |
101.20 |
| Price Vs.BV |
9.09 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
1,260.60 |
| NP(₹ Cr.) |
117.62 |
NP Var % |
35.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
3,847.63 |
| OPM |
12.80 |
NP |
232.25 |
| NP Var% |
103.92 |
EPS |
22.83 |
| PE |
67.46 |
|
|